IN8bio, Inc.
INAB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $10 | $9 | $416 | $560 |
| - Cash | $11 | $13 | $12 | $11 |
| + Debt | $3 | $3 | $4 | $5 |
| Enterprise Value | $2 | -$1 | $408 | $553 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$3 | -$4 | -$5 | -$6 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$5 | -$6 | -$6 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.85 | -1.24 | -0.067 | -0.085 |
| % Growth | 31.5% | -1,764.7% | 21.8% | – |
| Operating Cash Flow | -$4 | -$4 | -$3 | -$4 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$4 | -$4 | -$3 | -$4 |